OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC

Clinical trial NCT03806309 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03806309
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Locally Advanced Cancer Metastatic Cancer

Start date: 2021-04-10
Primary completion: 2024-12-09
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.